Cargando…
Effects of Somatostatin and Indomethacin Mono or Combination Therapy on High-risk Hyperamylasemia and Post-pancreatitis Endoscopic Retrograde Cholangiopancreatography Patients: A Randomized Study
BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) is a minimally invasive technique widely used to diagnose and treat pancreatic and biliary diseases; however, it is linked with imminent hyperamylasemia and post-ERCP pancreatitis (PEP). Somatostatin and indomethacin are the classic r...
Autores principales: | Wu, Zaoxuan, Xiao, Gui, Wang, Guiliang, Xiong, Liumei, Qiu, Ping, Tan, Sipin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545056/ https://www.ncbi.nlm.nih.gov/pubmed/37523580 http://dx.doi.org/10.1097/SLE.0000000000001202 |
Ejemplares similares
-
Preventive Role of Wire-Guided Cannulation to Reduce Hyperamylasemia and Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography
por: Mohammad Alizadeh, Amir Houshang, et al.
Publicado: (2012) -
Rectal indomethacin reduces the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis in low-risk patients
por: Abdelfatah, Mohamed M., et al.
Publicado: (2020) -
A grey zone of hyperamylasemia following endoscopic retrograde cholangiopancreatography: follow-up and differential diagnosis from acute pancreatitis
por: Cakir, Mikail, et al.
Publicado: (2020) -
Post-endoscopic retrograde cholangiopancreatography pancreatitis
por: Thaker, Adarsh M., et al.
Publicado: (2015) -
Role of Somatostatin in Preventing Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: An Update Meta-analysis
por: Hu, Jing, et al.
Publicado: (2016)